1. International Agency for Research on Cancer Agents classified by the IARC monographs, vol. 1–118.
http://monographs.iarc.fr/ENG/Classification/index.php
. Accessed 21 Dec 2016
2. Anderson-Otunu O, Akhtar S (2016) Chronic infections of the urinary tract and bladder cancer risk: a systematic review. Asian Pac J Cancer Prev 17:3805–3807
3. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med 2009(151):264–269
4. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1
5. Farah D, Hsieh M, Bayne C (2016) Role of urinary tract infection in non-schistosomiasis bladder cancer: protocol for a systematic review and planned meta-analysis. PROSPERO CRD42016053888.
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016053888